Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Novel therapies for relapsed/refractory multiple myeloma: how can we improve on "salvage" therapy?--introduction.

Jakubowiak A. Novel therapies for relapsed/refractory multiple myeloma: how can we improve on "salvage" therapy?--introduction. Semin Hematol. 2012 Jul; 49 Suppl 1:S1-2.

View in: PubMed

collapse authors with profiles